Studies on the control of bovine ostertagiasis using a morantel sustained release bolus

Gastrointestinal nematode infections of first-grazing season calves in Western Europe: general patterns and the effect of chemoprophylaxis

Research on the prevention of gastrointestinal nematode infections of cattle has mainly concentrated on comparing a specific chemoprophylactic treatment system to an untreated control group on a particular farm. Here, the results from analysis of 85 studies involving over 2000 first grazing season (FGS) calves put onto pasture for at least 4 months from late spring/early summer over a 26-year period in 13 countries in Western Europe are presented. Both control and chemoprophylactic treated FGS calf groups were considered. All chemoprophylactic systems (slow- and pulse-release boli, strategic treatments) were given early in the grazing season. Two general infection levels emerged--'sub-clinical' (32 studies) and 'clinical' (53 studies). The 'sub-clinical' infections were characterised by no clinical symptoms of parasitic gastroenteritis (PGE) being observed in the control groups. Mean faecal egg counts in the 'clinical' control groups were significantly higher than those for 'sub-clinical' control groups for almost the entire season with overall peaks of 275 and 100 EPG respectively. Maximum pasture larval counts were also significantly higher in the 'clinical' control groups with 44% of 'clinical' pastures > 10,000 L3 kg(-1) dry herbage by the end of the FGS, compared to only 15% of 'sub-clinical' pastures. There was a significant positive relationship between log transformed worm burdens from tracers put onto pastures for 2 weeks and the corresponding pasture larval count. No evidence of density dependence in tracer worm burden was observed. Weight gains in the 'clinical' control groups (375 g/day) were significantly lower than those of the 'sub-clinical' control groups (530 g/day). No symptoms of PGE were observed in any of the chemoprophylactic treated groups, but in those studies with an outbreak of PGE in the control group, the treated groups had significantly higher faecal egg and pasture larval counts than treated groups in 'sub-clinical' studies. The overall weight gain in chemoprophylactic treated calves in 'clinical' studies (600 g/day) was significantly lower than the chemoprophylactic treated calves in 'sub-clinical' studies (690 g/day), and was not significantly different from the weight gain of control calves in 'sub-clinical' studies. These results indicate that on heavily infected pastures, chemoprophylaxis will prevent PGE, but calves will still suffer production losses.

Gastrointestinal nematode infections of first-grazing season calves in Western Europe: associations between parasitological, physiological and physical factors

Analysis of 85 studies on gastrointestinal nematode infections in first-grazing season (FGS) calves is presented. The studies cover a 26-year period and were carried out in 13 countries in Western Europe. Both control and chemoprophylactic-treated (early in the season) FGS calf groups were included. In 53 of the 85 studies, clinical outbreaks of parasitic gastroenteritis (PGE) were observed during the FGS in the control groups. The mean initial age (and weight) of the control calf group was significantly associated with PGE outbreaks: 82% of control calf groups < or = 6 months of age had outbreaks of PGE, compared to only 33% of control calf groups > 6 months of age. In 92% of trials where the geometric mean faecal egg count (MFEC) was > or = 200 EPG on Day 56, PGE outbreaks were observed, but where it was < 200 EPG, only 29% had PGE. The use of these two factors in assessing the likelihood of PGE outbreaks in untreated calf groups in the future FGS is therefore, proposed. No chemoprophylactic-treated groups had PGE, but there was a highly significant negative relationship between maximum faecal egg counts in the chemoprophylactic-treated calves and the proportion of the trial covered by the different chemoprophylactic systems. Higher stocking densities were significantly associated with higher pasture contamination in both control and chemoprophylactic-treated calves. A highly significant positive relationship between the weight gained in the chemoprophylactic-treated groups and the estimated duration of the various chemoprophylactic systems was found, but there were large variations in weight gains (60-160 kg) between groups even with the same chemoprophylactic. Despite this and other highly significant associations, it was not possible to indicate what weight gains were obtained by the end of the FGS, from factors measured early in the FGS.

Gastrointestinal nematode infections of first-season grazing calves in Belgium: general patterns and the effect of chemoprophylaxis

Comparative analyses of the patterns of gastrointestinal nematode infections of first-grazing season cattle in Belgium are presented. The analysis involves 17 studies covering a 10 year period on 13 different farms in Flanders, Belgium. In all studies the calves were divided into an untreated control group, and one or two groups treated with chemoprophylactic systems. Two general infection levels emerged-'sub-clinical' (14 studies) and 'clinical' (three studies). The 'sub-clinical' infections were characterised by no clinical signs of parasitic gastroenteritis in the untreated control groups. Mean faecal egg counts remained low (less than 200), maximum pepsinogen levels only reached about 3500 mU tyrosine, and very small reductions in overall daily weight gain were observed compared with calves given chemoprophylaxis (less than 40 g day-1). Based on these results, on these 'sub-clinical' farms, chemoprophylaxis may not have been needed. In contrast, multiple salvage treatments of the control calf groups were required in the 'clinical' infections. Even with these salvage treatments mean faecal egg counts were high (more than 300), maximum pepsinogen levels were over 5500 mU tyrosine and there was a very large reduction in overall daily weight gain (more than 300 g day-1). However, it was not possible to predict either at turnout, or during the first month afterwards whether an infection on a particular farm would develop into a 'clinical' infestation. With the present data this prediction was possible from 8 weeks (Day 56) onwards, based on faecal egg counts and pasture larval contamination. It was also possible to predict using serum pepsinogen levels on Day 84. Therefore, one possible strategy for the effective control of gastrointestinal nematode infections of calves in temperate regions would be to evaluate faecal egg counts 2 months after turnout, and then only start treatment (i.e. metaphylaxis) if required.

World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine)

The first edition of the W.A.A.V.P. anthelmintic guidelines for ruminants was published in 1982. Since then improved parasitological procedures have been developed, new therapeutic and prophylactic products have appeared requiring different test methods, and registration authorities are requesting more detailed record keeping and data validation. This second edition addresses these developments and fulfills the original goal of publishing guidelines for high quality, scientifically valid testing standards for trials that would be accepted as proof of efficacy by registration authorities regardless of country of origin. This second edition includes updated guidance on standard parasitological procedures, dose titration, dose confirmation and clinical trials, and provides guidelines for evaluating products for efficacy against anthelmintic resistant parasites, persistence of activity and prophylactic activity. Tests for efficacy against nematodes, trematodes and cestodes are included.

Prophylaxis of bovine trichostrongylidosis in the alpine region: effect of pasture contamination on infections in calves receiving a morantel sustained-release trilaminate bolus in mid-July

In the alpine region, mixed grazing systems with cattle of different age, origin and prophylaxis against trichostrongylid infections are most common. Under these conditions the administration of anthelmintic devices to susceptible calves is frequently postponed to June or July to achieve a better protection during the period of increased pasture infectivity in summer and autumn. In a field experiment with 27 first-year grazing calves a morantel sustained-release trilaminate bolus (MSRT, Pfizer) was given to two groups (Groups A and B) of nine naturally infected calves each, on 22 July. Calves of Group B were moved to a clean pasture (B) 1 day later, whereas the calves of Group A remained on the previous pasture (A) together with nine untreated calves (Group C). The contamination with infective larvae (L3) on Pasture A remained below 1000 L3 kg-1 dry matter, which was sufficient to produce clinical parasitic gastroenteritis in five of nine control calves. The MSRT bolus reduced the mean egg output by more than 90% within 14 days after administration and prevented clinical parasitic gastroenteritis in the calves of Groups A and B. Owing to the persisting infection risk on Pasture A, the mean serum pepsinogen levels reached about 3000 mU tyrosine in the calves of Group A in September compared with approximately 2000 mU in Group B grazing the clean pasture. However, the differences in pasture contamination were not reflected in the mean bodyweight of the calves, which were 20 kg heavier at the end of the trial in both MSRT-treated groups compared with the control calves (P < 0.01). As there is a high probability that a moderate larval contamination is present on prealpine and alpine community pastures in summer, the metaphylactic use of an MSRT bolus in mid-July is likely to limit trichostrongylid infections within a subclinical range and thus provides sufficient protection of susceptible calves against parasitic gastroenteritis.

Control of gastrointestinal parasitism with an oxfendazole pulse-release anthelmintic device

The efficacy of a pulse-release oxfendazole bolus (OPRB) against gastrointestinal nematodes was evaluated under field conditions and compared with a sustained release morantel bolus (MSRB). Three groups of 10 calves were grazed from May to September on adjacent, similarly contaminated 3-acre paddocks. One group was dosed at turnout with the OPRB, the second group with the MSRB and the third group left as nontreated controls. Pasture larval counts peaked at greater than 60,000 larvae/kg dry weight of herbage in September on the control paddock, associated with a mean egg count of 1040 eggs/g faeces and clinical symptoms. A low rise in larval counts occurred on the MSRB plot, and also low helminth egg counts. On the OPRB plot, pasture larvae and faecal egg counts were recorded only intermittently; the September egg counts were only 3.5% of those of the controls; serum pepsinogen data showed a similar picture. At the end of the experiment, the OPRB calves had a mean weight advantage of 40 kg over the controls, and 12 kg over the MSRB group. Feed intakes were highest in the OPRB group in July and September.

Feed intake of grazing calves exposed to trichostrongyle infection and treated with the morantel sustained release bolus

Herbage intake was measured in two groups of 20 first-year grazing cattle. The animals in one group each received a morantel sustained release bolus at turnout to control nematode parasitism and the animals in the other group remained untreated. The latter group showed a mean peak faecal egg count of 655 eggs per gram (e.p.g.) in October associated with high serum pepsinogen concentration and clinical signs of ostertagiasis, compared with a peak of 119 e.p.g. in the treated group which remained in good health. In September the daily voluntary feed intake of the untreated animals was significantly depressed (94 g kg-1 body weight vs. 77 g kg-1 P less than 0.001), but no difference in digestive efficiency was recorded between the two groups. This difference in feed intake was associated with a 47 kg mean live weight advantage of the treated animals at housing.

Control of gastrointestinal parasitism in calves in Sweden over six years using the morantel sustained release bolus

During the 6 years 1979-1984, the use of the morantel sustained release bolus (MSRB) was monitored in first year grazing calves. Twenty-four to 30 calves each year were allotted to two groups (controls and MSRB-treated) and turned out at the end of May on the same pasture divided into two equal areas. After housing in October, each group was kept in boxes and fed concentrates, whey and hay. The calves were weighed at monthly intervals until the first animals were sent to slaughter. No cases of clinical ostertagiasis Type I were observed in the control calves during the grazing seasons, but in one year (1983) clinical signs occurred 2 weeks after housing. The number of overwintering larvae was influenced by pasture contamination the previous season and climatic conditions during winter and spring. The fecal egg output of the control animals during the grazing season did not reflect the level of pasture contamination at turnout. The build-up of pasture larval contamination during the later part of the grazing season was influenced by the climatic conditions. The fecal egg output of the treated calves was low during the entire grazing season resulting in a significantly reduced pasture contamination. A significantly reduced live-weight gain in the control calves was demonstrated at housing in five of the six years. When heavily infected at housing, the performance of the control calves was still influenced negatively during the fattening period indoors.

A comparison of nematode control programs for cattle in south western Victoria

Nematodiasis and its subsequent effect on production in Hereford weaner steers in western Victoria was studied during 1983 and 1984. In the first summer, steers were allocated to 2 replicates of 6 treatments--No treatment (Nil); Morantel slow release bolus in March (M1); Morantel bolus in March and June (M2); pour-on levamisole in January, May and July (R3); albendazole in January and July (V2) and albendazole in January, May and July, (V3). In 1984, treatment M2 was discontinued to provide extra replicates for Nil and M1. The replicate paddocks were 5 ha and were stocked with 7 and 8 steers in 1983 and 1984, respectively. Nematode egg counts in faeces, were generally less than 50 epg, indicating low numbers of adult nematodes. Faecal egg counts were highest in autumn and declined during the year. There was a significant (P = 0.02) effect of treatment on mean faecal egg count. Mean egg counts for treatment groups Nil and M1 were 16 and 10 epg above the overall mean (47 epg); those of the other treatments were 6 to 12 epg below the mean. There were no significant (P = 0.8) differences between treatments in the numbers of nematode larvae on pasture, during the experiment. At the end of both years of the experiment most nematodes (92%) were early fourth stage larvae of O. ostertagi. There were no consistent differences in nematode counts between treatments. There were no significant (P = 0.33) differences between treatments in bodyweights at any time during the experiment.(ABSTRACT TRUNCATED AT 250 WORDS)

Efficacy of morantel sustained release bolus against gastrointestinal nematodes in first season grazing Holstein calves

The efficacy of the morantel sustained release bolus (MSRB) in reducing gastrointestinal parasitism in first season grazing calves was evaluated during the summer--autumn grazing seasons of 1982 and 1983 in western Oregon. Each of 38 calves (1982) and 40 calves (1983) were randomly assigned to either control or treatment groups which were given MSRB on the day of turnout onto pasture. Mean worm burdens from tracer calves grazed with treated animals in 1982 and 1983 showed overall reductions of 86.4% (P greater than 0.05) and 84.3% (P less than 0.01), respectively, compared to tracers grazed with controls. Ostertagia ostertagi, Cooperia oncophora and Nematodirus helvetianus were the primary nematodes collected at necropsy. Twelve full-season 1982 tracer animals (6 treated and 6 control) indicated an 88.1% (P less than 0.05) overall reduction in mean worm burdens. Mean fecal worm egg per gram (EPG) counts of treated animals reflected a reduction of 69% (P less than 0.05) in 1982 and 90% (P less than 0.05) in 1983. Autumn inhibition of O. ostertagi was observed. In the 1982 trial the control animals showed a slight mean weight gain advantage over the treated group from Day 84 until Day 160 (trial termination) when the mean difference was 7.9 kg. The final mean weight gain advantage of treated animals in 1983 was 13.5 kg (P less than 0.05). These trials demonstrated that the MSRB was an effective anthelmintic for reducing gastrointestinal parasitism in grazing calves and for decreasing pasture larval contamination.

Some observations on the use of the morantel sustained-release bolus in first season-grazing calves on a Belgian dairy cattle farm

The efficacy of the morantel sustained-release bolus (MSRB) in controlling gastrointestinal parasites in first-season grazing calves was evaluated on a dairy cattle farm in Belgium. The calves grazed a pasture which had been used by bolus-treated animals in the three previous years. The effect of bolus administration was determined with respect to live weight gain, faecal egg shedding, herbage larval counts, serum pepsinogen levels and ELISA antibody titres. In spite of an incomplete reduction of faecal egg shedding during the first months of the grazing season, bolus administration resulted in the prevention of parasitic gastro-enteritis in the calves. A weight gain advantage of 35,2 kg of the bolus-treated animals over the controls was noted already at two months after turnout. This weight gain advantage was maintained until housing. The usefulness of serum pepsinogen values and ELISA antibody titres as parameters in prevention experiments is stressed. Both serological parameters gave more information concerning infection level than did the faecal egg output and the herbage larval counts.

Efficacy of morantel tartrate in a sustained release bolus on the control of subclinical gastrointestinal parasitism in first-year grazing dairy replacements

Thirty-four heifers (24 Holstein, 8 Ayrshire, 2 Jersey) and 12 Holstein steer calves were grouped into 23 blocks of 2 animals each according to breed, sex, and body weight. Animals in each block were randomly assigned to control or treated groups. The treated group received an anthelmintic bolus containing morantel tartrate before they were permitted access to pasture. A 2.6 ha pasture was divided in half with a double fence; the resulting two pastures had separate feed and water troughs. Steer calves were slaughtered upon termination of the trial to ascertain gastrointestinal parasite burdens. Two worm-free tracer calves were placed on each pasture every 2 mo and slaughtered after 4 wk of grazing to determine parasite infectivity of pastures. Herbage samples were obtained monthly and analyzed for infective larvae. The trial was conducted for 141 d during the grazing season. Treatment resulted in 90% reduction in infective larvae on pasture, 74% reduction in fecal worm-eggs, 91% reduction in adult worm burdens, and a trend toward reduced worm burdens in tracer calves by 52%. An overall average daily gain of .68 and .88 kg was obtained for control and treated animals. Reproductive data for the heifers remaining in the herd from the trial showed that treatment resulted in 44 less days to first breeding.

New methods of drug application for control of helminths

Several new ways have been developed of delivering anthelmintics to ruminants aimed particularly at reducing labour. For single doses, these include a semi-automatic rumen injector for giving insoluble drugs to cattle more conveniently and efficiently than by oral dosing, and the dermal application of levamisole which is, however, subject to seasonal variation in absorption. Sustained administration offers potentially a high level of preventive control but carries a greater risk of developing drug resistance. Even with the best available methods of group administration in feed supplements or drinking water, there remains some uncontrollable variation in individual intake. Intraruminal sustained release devices largely overcome this problem and constitute the most important new technology. They are represented at present by the commercially successful morantel sustained release bolus, and the more versatile Laby capsule which is under development for anthelmintic delivery. Other new applications include the possible development of synergists, potentiators and drug combinations, the special features of drugs which bind strongly to plasma proteins, and the new possibilities offered by a drug highly effective against all stages of Fasciola hepatica. In the general approach to anthelmintic application in helminth control, there have been advances in knowledge of helminth population biology which can lead to better timing of strategic dosing programs, which show that single treatments can have persistent benefits without a simultaneous reduction in infection rate, and which question the conventional view that control schemes require the treatment of all animals in the group.

Pathogenesis of trichostrongylosis

Trichostrongylosis is a major cause of impaired productivity in ruminants. The pathogenesis of such infections is principally associated with inappetence and increased losses of proteins into the gastrointestinal tract. Resultant changes in host metabolism account for the poor productivity in infected animals, although the precise mechanisms require further investigation. Studies are also required to investigate in greater detail the interactions between trichostrongylosis and the nutritional and immunological status of the host.

Effects of the use of a morantel sustained release bolus in first and second year grazing cattle

In an experiment carried out in 1981 and 1982, the effect of the use of a morantel sustained release bolus (Paratect bolus) on the weight gain and a number of parasitological parameters of cattle was studied. In the first year 42 calves were divided into 3 equal groups, one group was kept outside and treated with a bolus (B), the second group was kept outside and was not treated (C), while the third group remained indoors (I). Groups B and C were grazed separately on contaminated pasture. During the first months Group B had a negligible egg output. The egg output in the controls was much higher and in mid-August they had to be treated for parasitic gastroenteritis. At the end of the grazing season the advantage in weight gain of Group B was 20 kg compared with the controls. During the housing period the growth in the 3 groups was not significantly different. At the start of the second grazing season half the animals of Groups B, C and I received a bolus (Groups BB, CB and IB). The other half remained untreated (BC, CC and IC). The animals treated with a bolus in 1982 gained significantly more weight (64 g/day) than untreated animals. Heifers turned out for the first time (IB and IC) showed much less weight gain than heifers in their second grazing season. The heifers which had previously grazed in 1981 had a very low egg output compared with Groups IB and IC, although the level of egg output of the latter was also not very high (max, almost 40 (eggs per gram (EPG)). In faecal cultures of heifers of Group BC, CB and CC, no Cooperia oncophora-larvae were seen from May onwards, indicating a strong immunity against this species. In Group BB very low numbers of C. oncophora-larvae were observed. In Groups IB and IC, C. oncophora was present during the whole season. At the end of the first season the level of herbage infestation on the control pastures was much higher. In 1982 only slight differences in level of infestation between the pastures were observed. At the start of the season in 1982 serum pepsinogen levels were much higher in the groups which grazed in 1981, compared with the indoor-fed groups. Groups BC and CC had significantly higher levels than Groups BB and CB and all 4 groups always had higher levels than Groups IB and IC.(ABSTRACT TRUNCATED AT 400 WORDS)

Field efficacy of a morantel sustained release bolus for control of gastrointestinal nematodes in yearling steers

The efficacy of a morantel sustained release bolus (MSRB) for control of gastrointestinal nematodes in yearling steers was evaluated over a 6-month grazing period commencing on 26 March 1982. Three groups of 15 steers were allotted to the following treatments: Group 1 -- one MSRB at start of trial; Group 2 -- one therapeutic dose of thiabendazole at start of trial; Group 3 -- untreated control. The treatment groups were grazed separately. Parasite egg counts (EPG), herbage larval counts, pepsinogen levels and weight gains were monitored. Every other month, sets of 2 parasite-free tracer calves were placed in the pasture grazed by each treatment group and allowed to graze for 3 weeks before being subsequently necropsied for worm counts. At the end of the trial, 6 animals from each group were also necropsied for worm counts. The MSRB treatment resulted in significantly lower egg counts, fewer infective larvae on pasture, lower pepsinogen levels and lower worm burdens in tracer calves than was the case for the untreated group, but generally the levels were not significantly different from those associated with the thiabendazole treatment. The mean weight gain for the MSRB treated steers showed a significant advantage (70.9 lb) over the untreated animals, but was not significantly different from those which received thiabendazole. Total worm counts at the end of the trial were not different from any treatment group.

Potential problems associated with the controlled release of anthelmintics in grazing animals

A high, constant and sustained release of drug appears to be a major requirement to avoid a late season rise in pasture infectivity that may result in production losses in calves in autumn or Type II osteragiasis in the following spring. The timing of administration is of crucial importance and will vary in regions of different epidemiology, such as between northern and southern United States. Lack of a standard and reliable technique for pasture larval counts has resulted in some negative or erratic results which are open to question. Although controlled release anthelmintics offer advantages of convenience, a comparison of the economic benefits at present favours prophylactic treatment of dairy heifers with conventional anthelmintics 3 and 6 weeks after spring turnout in northern regions of the Northern Hemisphere. There is a serious risk that boluses based on controlled release by diffusion will behave like slow decaying insecticides and select strongly for drug resistance, especially if farmers administer them in succession throughout the grazing season. There are, however, 2 features in the design of a controlled release device that in theory may minimize the risk of rapid selection for resistance: a high and constant release of anthelmintic followed by a rapid decline to zero as the device becomes exhausted. Under these conditions, the device may even prolong the useful life of an anthelmintic to which resistance has already developed. This paper was presented at Pfizer Symposium on The Application of Sustained Release Anthelmintic Dosage Forms in the Control of Parasites in Grazing Animals at the World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) 10th International Conference, 18-20 August 1983, Perth, W.A., Australia.

Low-dosage phenothiazine in the prophylaxis of trichostrongylid infection in calves

Phenothiazine (PTZ) given indoors to calves artificially infected with Ostertagia ostertagi and Cooperia oncophora showed ovicidal activities of 100, 93, 98 and 85% respectively at daily doses of 9, 8, 7 and 6 mg kg-1. In a grazing study, one group of calves was treated with PTZ via the drinking water, using a "Profel" liquid dispenser. The dispenser was calibrated to add PTZ to the water at a daily dose of 7 mg kg-1, but in practice the dose far exceeded this amount. A dose of 7 mg kg-1 day-1 was given manually to a second group and a third group acted as control, receiving no PTZ. PTZ-induced photosensitivity was widespread in the first group due to over-dosage of medicament by the dispenser and was suspected in one calf in the manually dosed group. PTZ in both treated groups showed marked ovicidal activity and, apparently as a result of this, caused striking reductions in trichostrongylid infection on the pasture and in the calves as evidenced by pasture larval counts, calves' egg counts, pepsinogen levels and live weight gains. Necropsy worm counts showed that the PTZ medication prevented heavy infection by arrested as well as by adult Ostertagia. The reduced infection on the treated calves' pasture was carried over for a second grazing season. Untreated calves grazing the pasture in that season showed lower infection and improved weight gains up to mid-September compared with calves on the control pasture. These effects did not persist for the whole of the second season.

Grazing study in Ireland using the morantel sustained release bolus for controlling nematodiasis in calves

The morantel sustained release bolus was administered at turnout to first-season grazing calves in order to assess its efficacy in the seasonal control of infection by nematode parasites in Ireland. The pastures grazed by control calves showed a marked increase in gastrointestinal trichostrongylid infective larvae by September, while numbers of infective larvae on pasture grazed by bolus-treated calves remained at a low level throughout the grazing season. In consequence, the controls showed significantly higher worm egg counts in late season and significantly higher worm burdens (mainly Ostertagia spp) at necropsy carried out in November on representative number of principal animals selected from each group. These reduced worm burdens were attributed to the suppression of egg output during the early part of the season as a result of treatment with the morantel sustained release bolus at turnout in the spring. Pasture contamination with Dictyocaulus viviparus larvae was present on all treatment pastures. The bolus-treated calves however were subjected to an increase in D. viviparus infection which occurred on their pasture in late season after the active life of the bolus had expired. It was concluded that bolus treatment delayed (rather than prevented) the buildup of D. viviparus infection on the pasture by 60-90 days.

The use of the morantel sustained release bolus under special farm practices (deprime system) in France

The efficacy of the morantel sustained release bolus in controlling gastrointestinal and lungworm parasites when used in first-season grazing animals which followed older animals onto spring pasture (deprime system) was assessed in three trials conducted in Normandy, France. In each trial first-season grazing calves were equally allocated onto two separate but equivalent paddocks where they remained throughout the grazing season. A morantel sustained release bolus was administered to one group of animals at turnout, the other group remained as controls. The effect of the treatment on contamination of pasture (herbage larval counts and tracer worm counts), on faecal worm egg and lungworm larval counts, and on weight gain performance of the principal animals was assessed. In all three trials, worm egg output in the bolus-treated animals was substantially lower throughout the season compared with the control animals. Worm burdens of tracer calves grazing pastures of the treated cattle were also reduced compared with tracer calves grazing control pastures. Clinical parasitic gastroenteritis occurred in the control animals but not in the bolus-treated animals in one trial. Overall the bolus-treated animals outperformed the controls by a mean weight gain advantage of 10.5 kg (P less than 0.01).

Morantel sustained release bolus: a new approach for the control of trichostrongylosis in Austrian cattle

The efficacy of a morantel sustained release bolus to control gastrointestinal parasitism during two consecutive grazing seasons was assessed in replacement dairy heifers raised under field conditions in Austria. Thirty calves were randomly allotted into two equal groups and maintained throughout the 1979 summer pasturing season on adjacent pastures of equal size with identical grazing history. Twenty-four of the thirty calves used in 1979 were monitored throughout 1980, each animal remained in the same treatment group as the previous year and grazed the same pastures as the previous year. In both 1979 and 1980 the bolus was administered to each animal in the treated group one week before turnout onto spring pastures, while the control animals received no anthelmintic treatment during either year. The efficacy of the bolus was assessed by comparison of faecal worm egg counts, herbage larval counts, worm counts from tracer and principal trial animals, weight gains and by the incidence of clinical disease found in both tracer and trial animals throughout the grazing season. Milk production was also monitored for all animals in both treatment groups during the first lactation. The system of treatment used in the present study with the morantel sustained release bolus was highly effective in preventing a significant buildup of infective larvae on pasture to the end of the grazing season in both years. In 1979 worm counts of tracer calves grazed on the treated pastures in mid-August were similar to those recorded at the beginning of the season, while worm counts in the control tracers were five times the total found at the beginning of the season. In 1979 the bolus-treated calves outperformed the control group by 34.8 kg (P less than 0.001) over the 168-day grazing period. These results demonstrated that administration of the bolus to calves at the time of turnout onto spring pastures was most effective both in controlling parasites within the cattle themselves and in reducing the level of parasite contamination. During the second grazing season (1980) no beneficial effect in weight gain was observed due to the second bolus treatment. Weight gains realized during the first year, however, largely remained through the second year and the bolus-treated heifers reached breeding weight on average 19 days earlier. No difference in milk yield was observed between the treated and control animals during thier first year of lactation.

The effects of the use of the morantel sustained release bolus system on calves grazing a highly contaminated pasture in The Netherlands

The efficacy of the morantel sustained release bolus system for the control of parasitic gastroenteritis in calves was evaluated in the Netherlands. The effect of bolus administration to calves, either on May 1 at the beginning of the summer grazing season or on June 12 after the pasture was mown for silage, was determined in respect of liveweight gain, faecal worm egg output, serum pepsinogen values and worm burdens. In addition, pairs of tracer calves were turned out with each group every four weeks and sacrificed for worm counts in order to monitor pasture larval contamination throughout the grazing period. Compared with nontreated control calves, the worm egg outputs of the bolus-treated calves turned out (Nematodirus helvetianus), while the bolus-treated calves turned out on June 12 had a corresponding reduction of 95 and 100 percent. Over the grazing season the average weight gain of bolus-treated calves turned out on May 1 was 34 kg more than nontreated controls turned out at the same time. Difference in weight gain of the treated and control calves turned out late in the season was 10.5 kg in favour of the treated group. The postmortem worm counts were highest in the control calves turned out early and lowest in the bolus-treated calves turned out late. All tracer calves placed on the paddock grazed by control calves (turned out early) died from parasitic gastroenteritis from July onwards while those from the paddock grazed by the control calves (turned out late) died from parasitic gastroenteritis from September onwards. All the tracer calves placed on the paddocks grazed by bolus-treated calves survived until the intended slaughter date.

The control of parasitic gastroenteritis of grazing cattle in Normandy, France using the morantel sustained release bolus

The efficacy of the morantel sustained release bolus in controlling parasitic gastroenteritis in 153 first-season grazing cattle was assessed in three separate field trials conducted in Normandy, France. In each trial, comparisons were made on weight gain performance and parasitology data (faecal worm egg counts, herbage larval counts and- in two of the trials- worm counts from principal animals sacrificed at the end of the grazing season) when bolus treatment was given either at spring turnout or in mid-season in order to determine the optimum time for bolus administration. Cattle were allocated into three groups, each group maintained on a separate but equivalent paddock constructed from the division of a larger pasture. A morantel sustained release bolus was administered to one group of animals at the time of turnout and to a second group of animals in midsummer. The third group of animals in each trial remained nontreated. The effect of the treatment on the contamination of pasture, and parasite levels and weight gain of the principal trial animals was assessed. Similar results were observed in all three trials. Faecal worm egg counts were reduced during the first part of the grazing season in animals receiving the bolus at turnout compared with mid-season treated animals where egg counts followed a pattern similar to the controls until bolus treatment at which time counts abruptly dropped to a low level. Likewise, levels of infective larvae on pastures grazed by control and mid-season treated animals followed similar patterns, increasing to a high level in late summer, while larval levels on pastures grazed by early-season treated animals remained at low levels throughout most of the season. Serum pepsinogen levels, worm counts and weight gain reflected the results from faecal worm egg and herbage larval counts indicating that early-season treatment with the bolus provided the most efficient treatment time for controlling parasitic gastroenteritis throughout the grazing season. The overall mean weight gain advantage of the early-season bolus-treated animals over the controls was 37.2 kg (P less than 0.01) while the advantage of the mid-season treated animals over controls was 13.7 kg.

The use of the morantel sustained release bolus in second-season grazing cattle

The efficacy of the morantel sustained release bolus in controlling gastrointestinal helminth infection in second-season grazing cattle was investigated on a total of seven farms in southeast England. On each farm only animals which had grazing experience from the previous summer pasturing season were used. The animals on each farm were allotted into two equal groups and turned out onto divided pastures of equal size. All the cattle in one group received a bolus at turnout while the cattle in the other group remained as nontreated controls. Assessment of the efficacy of treatment was based on comparisons of faecal worm egg output, herbage larval counts, weight gain, and the incidence of clinical parasitic gastroenteritis during the grazing season. Use of the morantel sustained release bolus led to the cessation of worm egg excretion in bolus-treated cattle during the early part of the grazing season thereby preventing a subsequent buildup of infective larvae on pasture. Although the overall results from worm egg and herbage larval counts demonstrated little measurable effect of treatment, clinical parasitic gastroenteritis was prevented in two trials where control animals became clinically affected by parasitism. Overall, the bolus-treated animals outperformed the controls by a mean of 15.1 kg (P less than 0.001).

The use of a morantel sustained release bolus in the seasonal control of parasitic gastroenteritis in second-season cattle

The efficacy of a morantel sustained release bolus was evaluated during the 1980 summer grazing season in 216 yearling, second-season cattle in nine trials in West Germany. In five trials individual farms were used, in which medicated and control groups could be grazed on adjacent pastures. In four additional trials medicated and control groups were maintained on separate farms where the sites and management practice were matched as far as possible. Faecal worm egg counts, herbage larval counts and weight gain were monitored at regular intervals throughout the season. The faecal output of gastrointestinal nematode eggs was reduced by 55.8 percent in the medicated animals during the period from May to early August, while worm egg counts were equal to that of the control animals during the later part of the season. Herbage larval counts were similar on pastures grazed by medicated and nonmedicated cattle. In the five trials where individual farms were used the average daily weight gains over the entire grazing period were 900 (+/- 222) g/animal/day in the medicated group compared with 826 (+/- 263) g/animal in the nonmedicated cattle, a non-significant advantage. No advantage for the treated over the control groups was detected in the additional 4 trials but this was attributed largely to the difficulty in obtaining comparable groups of animals in comparable grazing conditions in "matching" farms, leading to inter-farm variation.

Studies on the interaction between an irradiated bovine lungworm vaccine and a morantel sustained release bolus

The interaction of the morantel sustained release bolus with the development of immunity in calves vaccinated with two doses of gamma irradiated (40 Kr) Dictyocaulus viviparus larvae was investigated under laboratory conditions. A total of 37 helminth-naive calves were used. Eight calves were used in the first part of the study to test the efficacy of a larval vaccine prepared by using gamma rays delivered from a cobalt source. In the second part of the study, four groups of four groups of four calves each were vaccinated and of these, all the animals in two groups each received a bolus. The remaining three groups (two groups of four and one group of five calves each) remained nonvaccinated with each animal in one group receiving a bolus. All the calves were challenged with approximately 2000 lungworm larvae four months postvaccination. In order to simulate possible field conditions, two of the vaccinated groups and two of the nonvaccinated groups were given a trickle infection of 800 lungworm larvae over a four-week period, three months prior to challenge. Based on a comparison of clinical signs, pathology and lungworm burdens at necropsy, the vaccination of the calves conferred a significant degree of protection (P less than 0.001) to a subsequent challenge compared with controls. The introduction of a morantel sustained release bolus and/or a trickle infection had no effect on the high degree of protection engendered by the vaccination. Nonvaccinated calves given a trickle infection, with or without a bolus, were also highly immune to challenge.

A two-year study on the anthelmintic effect of a pregrazing treatment with the morantel sustained release bolus in first season grazing cattle in Sweden

During two consecutive grazing seasons, the strategic use of the morantel sustained release bolus (MSRB) was monitored each year in first season grazing calves (maintained both years on the same pasture). The object of the study was to determine the effects of bolus treatment in young calves during successive years on the level of pasture larval contamination available at the beginning of the second year, and on the pattern of pasture recontamination that occurred during the second year. The level of worm burdens acquired in the trial animals at the end of the grazing season was determined both years. Tracer worm counts were determined during the first year of the study, while faecal worm egg counts, herbage larval counts and weight gain were monitored both years. During the first year (1979) the selected pasture was equally divided into three separate paddocks. Two paddocks were grazed by control calves, while each animal grazing the third paddock received a bolus at the time of turnout. During the second year (1980) three groups of calves were used. One group was treated with the bolus and grazed the same paddock as calves treated with the bolus the previous year. The second group was treated with the bolus and grazed the control paddock from the previous year, while the third group of calves remained nontreated and grazed the remaining paddock grazed by control calves from the previous year. As a result of the bolus treatment during the first year, the number of overwintering nematode larvae recovered the following spring was considerably lower than the number recorded on the paddock grazed previously by control animals. Worm counts and efficacy calculations demonstrated that worm burdens accumulated during the season were considerably lower in the bolus treated cattle during the second year than during the first. These parasitological differences were reflected in the weight gain comparisons between the treated and control cattle. Although significantly improved weight gains were recorded for both groups of treated cattle compared with the control cattle during the second year, the treated cattle grazing the treated paddock had a greater improvement than the treated cattle grazing the control paddock from the previous year.